Literature DB >> 15150775

Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development.

Brigitte Royer-Pokora1, Manfred Beier, Markus Henzler, Rita Alam, Valérie Schumacher, Angela Weirich, Vicki Huff.   

Abstract

We report here 24 new Wilms tumor (WT) patients with germline WT1 alterations and a synopsis of our own previously described and literature cases in whom age of tumor-onset, gender, and laterality were known. This combined database contains 282 patients, 117 patients with and 165 without WT1 germline alterations. Using this information we have determined the median age of tumor-onset for patients with (12.5 months) and without WT1 gene alterations (36 months). The earliest onset was in patients with truncation (12 mo, 66 patients), followed by missense mutations (18 mo, 30 patients) and deletions (22 mo, 21 patients). Patients with the two most frequent nonsense mutations R362X and R390X and the Denys-Drash syndrome (DDS) hot spot mutation R394W/Q/L had a very early onset (9, 12, and 18 mo, respectively). The highest number of bilateral tumors was observed in the group of truncation mutations, with a higher percentage of bilateral tumors when truncations occurred in the 5' half of the WT1 gene. In addition to genital tract anomalies (GU), early onset nephrotic syndrome with diffuse mesangial sclerosis and stromal-predominant histology, tumor bilaterality, and early age of onset can now be added to the list of risk factors for carrying a germline WT1 mutation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15150775     DOI: 10.1002/ajmg.a.30015

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  46 in total

1.  Broad and unexpected phenotypic expression in Greek children with steroid-resistant nephrotic syndrome due to mutations in the Wilms' tumor 1 (WT1) gene.

Authors:  Spyridon Megremis; Andromachi Mitsioni; Irene Fylaktou; Sofia Kitsiou Tzeli; Filadelfia Komianou; Constantinos J Stefanidis; Emmanuel Kanavakis; Joanne Traeger-Synodinos
Journal:  Eur J Pediatr       Date:  2011-04-16       Impact factor: 3.183

2.  The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis.

Authors:  Fei Gao; Sourindra Maiti; Nargis Alam; Zhen Zhang; Jian Min Deng; Richard R Behringer; Charlotte Lécureuil; Florian Guillou; Vicki Huff
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-28       Impact factor: 11.205

3.  Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.

Authors:  Jane Lange; Susan M Peterson; Janice R Takashima; Yevgeny Grigoriev; Michael L Ritchey; Robert C Shamberger; J Bruce Beckwith; Elizabeth Perlman; Daniel M Green; Norman E Breslow
Journal:  J Urol       Date:  2011-06-17       Impact factor: 7.450

4.  Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.

Authors:  Anja Lehnhardt; Claartje Karnatz; Thurid Ahlenstiel-Grunow; Kerstin Benz; Marcus R Benz; Klemens Budde; Anja K Büscher; Thomas Fehr; Markus Feldkötter; Norbert Graf; Britta Höcker; Therese Jungraithmayr; Günter Klaus; Birgit Koehler; Martin Konrad; Birgitta Kranz; Carmen R Montoya; Dominik Müller; Thomas J Neuhaus; Jun Oh; Lars Pape; Martin Pohl; Brigitte Royer-Pokora; Uwe Querfeld; Reinhard Schneppenheim; Hagen Staude; Giuseppina Spartà; Kirsten Timmermann; Frauke Wilkening; Simone Wygoda; Carsten Bergmann; Markus J Kemper
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-27       Impact factor: 8.237

5.  Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.

Authors:  Gil Chernin; Virginia Vega-Warner; Dominik S Schoeb; Saskia F Heeringa; Bugsu Ovunc; Pawaree Saisawat; Roxana Cleper; Fatih Ozaltin; Friedhelm Hildebrandt
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

6.  A novel missense mutation of Wilms' Tumor 1 causes autosomal dominant FSGS.

Authors:  Gentzon Hall; Rasheed A Gbadegesin; Peter Lavin; Guanghong Wu; Yangfan Liu; Edwin C Oh; Liming Wang; Robert F Spurney; Jason Eckel; Thomas Lindsey; Alison Homstad; Andrew F Malone; Paul J Phelan; Andrey Shaw; David N Howell; Peter J Conlon; Nicholas Katsanis; Michelle P Winn
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

7.  Renal failure from birth-AKI or CKD? Answers.

Authors:  Sean Carter; Abhijit Dixit; Andrew Lunn; Anjum Deorukhkar; Martin Christian
Journal:  Pediatr Nephrol       Date:  2016-02-18       Impact factor: 3.714

8.  [Denys-Drash syndrome. Experience gathered in Erlangen illustrated by two case reports].

Authors:  V Zugor; M Zenker; J Dötsch; K M Schrott; G E Schott
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

9.  A familial WT1 mutation associated with incomplete Denys-Drash syndrome.

Authors:  Chunhua Zhu; Fei Zhao; Weizhen Zhang; Hongmei Wu; Ying Chen; Guixia Ding; Aihua Zhang; Songming Huang
Journal:  Eur J Pediatr       Date:  2013-05-29       Impact factor: 3.183

10.  A novel WT1 mutation in a 46,XY boy with congenital bilateral cryptorchidism, nystagmus and Wilms tumor.

Authors:  Monica Terenziani; Michele Sardella; Beatrice Gamba; Maria Adele Testi; Filippo Spreafico; Gianluigi Ardissino; Fausto Fedeli; Franca Fossati-Bellani; Paolo Radice; Daniela Perotti
Journal:  Pediatr Nephrol       Date:  2008-12-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.